Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
April 16, 2024 04:46 ET
|
Dimensional Fund Advisors Ltd
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
Pelacarsen (TQJ230) Drug Research Report 2024: 7mm Market Size, Forecasts, and Emerging Insights 2019-2032 - An Investigational Antisense Medicine Designed to Reduce Apolipoprotein(a) in the Liver
April 16, 2024 04:43 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Pelacarsen Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering."Pelacarsen Market Size,...
Olpasiran (formerly AMG 890) Drug Research Report 2024: A Small Interfering RNA Designed to Lower the Body's Production of Apolipoprotein - 7MM Market Size, Forecast, and Emerging Insights 2019-2032
April 16, 2024 04:39 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Olpasiran Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering."Olpasiran Market Size,...
Selatogrel for AMI Drug Research Report 2024: A Potent, Highly Selective, Fast-Acting, and Reversible P2Y12 Receptor Antagonist - 7MM Market Size, Forecast, and Emerging Insights 2019-2032
April 16, 2024 04:37 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Selatogrel Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering."Selatogrel Market Size,...
Danske Bank A/S, transactions by persons discharging managerial responsibilities
April 16, 2024 04:36 ET
|
Danske Bank A/S
16 April 2024 Notification no. 37/2024 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. In...
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
April 16, 2024 04:35 ET
|
Boehringer Ingelheim
Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV®Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8...
FDY-5301 Drug Research Report 2024: An Elemental Reducing Agent Containing Sodium Iodide for Which Faraday has Obtained a Method of Use Patent Protection in 7MM - Insights and Forecasts 2019-2032
April 16, 2024 04:34 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "FDY-5301 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering."FDY-5301 Market Size,...
[Latest] Global Organic Peroxide Market Size/Share Worth USD 3.5 Billion by 2033 at a 4.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 16, 2024 04:30 ET
|
Custom Market Insights
Austin, TX, USA, April 16, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Organic Peroxide Market Size, Trends and Insights By Type (Ketone Peroxide,...
Instrument Transformers Market is Anticipated to Reach $10.6 billion by 2030 at a CAGR of 5.8% – Report by MarketsandMarkets™
April 16, 2024 04:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, April 16, 2024 (GLOBE NEWSWIRE) -- Instrument Transformers Market size is projected to grow from USD 7.1 billion in 2023 to USD 10.6 billion by 2030, at a CAGR of 5.8% according to a new...
Aktia's interim report for January–March will be published on Tuesday 30 April 2024 at 8.00 a.m.
April 16, 2024 04:30 ET
|
Aktia Bank Plc
Aktia Bank PlcPress release16 April 2024 at 11.30 a.m. Aktia's interim report for January–March will be published on Tuesday 30 April 2024 at 8.00 a.m. Aktia's interim report for January–March 2024...